Advertisement
Screener

AngioDynamics, Inc. (ANGO) ROE

ANGIODYNAMICS INC ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • ANGIODYNAMICS INC roe for the quarter ending 2026-05-31 was -21.51%, a change of -2.93% year-over-year.
  • ANGIODYNAMICS INC roe for the quarter ending 2026-02-28 was -18.11%, a change of 4.16% year-over-year.
  • ANGIODYNAMICS INC roe for the quarter ending 2025-11-30 was -15.71%, a change of 104.61% year-over-year.
  • ANGIODYNAMICS INC roe for the quarter ending 2025-08-31 was -17.95%, a change of 105.68% year-over-year.
  • ANGIODYNAMICS INC roe for fiscal 2026 was -21.51%, a change of -2.93% from fiscal 2025.
  • ANGIODYNAMICS INC roe for fiscal 2025 was -18.58%, a change of 71.09% from fiscal 2024.
  • ANGIODYNAMICS INC roe for fiscal 2024 was -89.67%, a change of -75.81% from fiscal 2023.
  • ANGIODYNAMICS INC roe for fiscal 2023 was -13.86%, a change of -7.61% from fiscal 2022.
Available history
2010-05-31 to 2026-05-31
Data captured

Historical ROE

DateROENet income 12 monthNet income 3 monthShareholder equity
2026-05-31-21.51%-$36.74M-$11.40M$170.83M
2026-02-28-18.11%-$31.39M-$8.08M$173.36M
2025-11-30-15.71%-$27.71M-$6.35M$176.33M
2025-08-31-17.95%-$32.1M-$10.90M$178.86M
2025-05-31-18.58%-$33.99M-$6.05M$182.97M
2025-02-28-22.27%-$41.39M-$4.41M$185.87M
2024-11-30-120.32%-$224.72M-$10.74M$186.77M
2024-08-31-123.63%-$243.03M-$12.80M$196.58M
2024-05-31-89.67%-$184.35M-$13.45M$205.59M
2024-02-29-87.96%-$192.37M-$187.74M$218.7M
2023-11-30-3.52%-$14.12M-$29.05M$401.23M
2023-08-311.51%$6.45M$45.88M$427.8M
2023-05-31-13.86%-$52.44M-$21.47M$378.3M
2023-02-28-9.37%-$37.24M-$9.48M$397.66M
2022-11-30-8.02%-$32.71M-$8.49M$407.96M
2022-08-31-7.87%-$32.58M-$13.00M$414.04M
2022-05-31-6.25%-$26.55M-$13.00M$424.49M
2022-02-28-9.25%-$39.75M-$4.96M$429.69M
2021-11-30-8.87%-$38.34M-$8.35M$432.37M
2021-08-31-7.86%-$34.25M-$6.97M$435.95M
2021-05-31-7.18%-$31.55M-$19.47M$439.46M
2021-02-28-37.18%-$169.15M-$3.54M$454.94M
2020-11-30-37.71%-$171.31M-$4.27M$454.34M
2020-08-31-37.31%-$169.78M-$4.27M$455.05M
2020-05-31-36.67%-$166.79M-$157.07M$454.87M
2020-02-298.05%$49.15M-$5.71M$610.48M
2019-11-309.07%$55.66M-$2.74M$613.81M
2019-08-319.86%$60.53M-$1.27M$614.07M
2019-05-319.98%$61.34M$58.87M$614.82M
2019-02-280.82%$4.57M$796.00K$554.08M
2018-11-303.24%$17.79M$2.14M$549.56M
2018-08-312.92%$15.9M-$469.00K$544.89M
2018-05-313.01%$16.34M$2.10M$542.6M
2018-02-280.25%$1.32M$14.02M$538.33M
2017-11-30-1.88%-$9.81M$249.00K$521.22M
2017-08-310.71%$3.67M-$35.00K$517.88M
2017-05-310.97%$5.01M-$12.91M$515.03M
2017-02-28-4.73%-$25.15M$2.89M$531.75M
2016-11-30-5.24%-$27.45M$13.73M$523.35M
2016-08-31-8.10%-$41.52M$1.30M$512.72M
2016-05-31-8.59%-$43.59M-$43.08M$507.23M
2016-02-29-0.20%-$1.1M$594.00K$550.8M
2015-11-30-1.09%-$5.96M-$334.00K$547.73M
2015-08-31-0.78%-$4.29M-$775.00K$547.18M
2015-05-31-0.56%-$3.04M-$588.00K$545.1M
2015-02-28-0.73%-$3.99M-$4.15M$543.57M
2014-11-300.88%$4.79M$1.07M$543.24M
2014-08-310.59%$3.19M$284.00K$539.59M
2014-05-310.44%$2.35M-$1.22M$536.89M
2014-02-280.48%$2.57M-$4.26M$537.69M
2013-11-30-0.55%-$2.93M$1.34M$529.73M
2013-08-31-0.13%-$703,000.00$470.00K$528.45M
2013-05-31-0.13%-$703,000.00-$1.22M$526.32M
2013-02-28-1.26%-$6.66M-$992.00K$527.36M
2012-11-30-1.41%-$7.44M-$261.00K$526.69M
2012-08-31-1.35%-$7.08M-$721.00K$523.88M
2012-05-31-1.02%-$5.33M-$7.03M$523.31M
2012-02-290.25%$1.03M-$1.77M$411.36M
2011-11-301.61%$6.61M$2.33M$410.85M
2011-08-311.85%$7.56M$1.37M$409.3M
2011-05-311.99%$8.08M-$901.00K$405.64M

Annual ROE

DateROENet income 12 monthShareholder equity
2026-05-31-21.51%-$36.74M$170.83M
2025-05-31-18.58%-$33.99M$182.97M
2024-05-31-89.67%-$184.35M$205.59M
2023-05-31-13.86%-$52.44M$378.3M
2022-05-31-6.25%-$26.55M$424.49M
2021-05-31-7.18%-$31.55M$439.46M
2020-05-31-36.67%-$166.79M$454.87M
2019-05-319.98%$61.34M$614.82M
2018-05-313.01%$16.34M$542.6M
2017-05-310.97%$5.01M$515.03M
2016-05-31-8.59%-$43.59M$507.23M
2015-05-31-0.62%-$3.39M$545.1M
2014-05-310.44%$2.35M$536.89M
2013-05-31-0.20%-$1.05M$526.32M
2012-05-31-1.02%-$5.33M$523.31M
2011-05-311.99%$8.08M$405.64M
2010-05-313.15%$12.31M$391.35M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
SI-BONE, Inc. (SIBN)United States$0.830B-49.82